Sophie Langouet

Institut national de la santé et de la recherche médicale

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (13)

Amita Bansal

Research Fellow/Lecturer

Australian National University

AUSTRALIA

View details

Jan Vondracek

professor

CZECH REPUBLIC

View details

Karine Audouze

Professor

Université Paris-Saclay

FRANCE

View details

Francois BRION

Institut National de l'Environnement Industriel et des Risques

FRANCE

View details

Patrick Babin

University of Bordeaux

FRANCE

View details

Hugo Oliveira

FRANCE

View details

PALOMA ALONSO MAGDALENA

Associate Professor

SPAIN

View details

Pavel Babica

Přírodovědecká Fakulta, Univerzita Karlova

CZECH REPUBLIC

View details

SAURABH CHATTERJEE

Professor

University of California, Irvine

UNITED STATES

View details

Min Ji kim

INSERM U1148

FRANCE

View details

Christopher Kassotis

Assistant Professor

Wayne State University

UNITED STATES

View details

Anja Knoll-Gellida

University of Bordeaux

FRANCE

View details

Lisa Connolly

The Queen's University Belfast

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sophie Langouet

Research Interests

Explore related searches

Contact this professor

Articles (12)

Hepatotoxicity of cyanotoxin microcystin-LR in human: Insights into mechanisms of action in the 3D culture model Hepoid-HepaRG

Assessment of endocrine disruptor impacts on lipid metabolism in a fatty acid-supplemented HepaRG human hepatic cell line

ReadEDTest: A tool to assess the readiness of in vitro test methods under development for identifying endocrine disruptors.

Combinatorial pathway disruption is a powerful approach to delineate metabolic impacts of endocrine disruptors.

Obesity III: Obesogen assays: Limitations, strengths, and new directions.

In vitro long term differentiation and functionality of three-dimensional bioprinted primary human hepatocytes: application for in vivo engraftment

Obesity II: Establishing causal links between chemical exposures and obesity

Corrigendum to “Obesity II: Establishing causal links between chemical exposures and obesity” [Biochem. Pharmacol. 199 (2022) 115015] (Biochemical Pharmacology (2022) 199, (S0006295222001095), (10.1016/j.bcp.2022.115015))

Corrigendum to “Obesity III: Obesogen assays: Limitations, strengths, and new directions” [Biochem. Pharmacol. 199 (2022) 115014](S0006295222001083)(10.1016/j.bcp.2022.115014)

Constructing xenobiotic maps of metabolism to predict enzymes catalyzing metabolites capable of binding to DNA

Generation of proliferating human adult hepatocytes using optimized 3D culture conditions

DMSO-free highly differentiated HepaRG spheroids for chronic toxicity, liver functions and genotoxicity studies

Collaborators (13)

Amita Bansal

Jan Vondracek

Karine Audouze

Francois BRION

Patrick Babin

Hugo Oliveira

PALOMA ALONSO MAGDALENA

Pavel Babica

SAURABH CHATTERJEE

Min Ji kim

Christopher Kassotis

Anja Knoll-Gellida

Lisa Connolly

Make your next move.